ArticleBioData mining2022
Benchmarking AutoML frameworks for disease prediction using medical claims.
Article in BioData mining, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Validation and Development of Claims-Based Algorithms for Identifying Thyroid Eye Disease Using the IRIS Registry-Komodo Linked Database.Journal of clinical medicine · 2026Article
- AutoML-Multiverse: An Instability-Aware Framework for Quantifying Analytic Variability in Alzheimer's Disease Machine-Learning Studies.medRxiv : the preprint server for health sciences · 2026Article
- Validation of algorithms for identifying people living with HIV in French medico-administrative databases: implications for HIV surveillance.BMC medical research methodology · 2026Article
- Machine learning-based prediction of fever among under-five children in Ethiopia: A national-level study.PloS one · 2026Article
- Explainable AI based cervical cancer prediction using FSAE feature engineering and H2O AutoML.Scientific reports · 2025Article
- Leveraging Explainable Automated Machine Learning (AutoML) and Metabolomics for Robust Diagnosis and Pathophysiological Insights in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).Diagnostics (Basel, Switzerland) · 2025Article
- Use of Automated Machine Learning to Detect Undiagnosed Diabetes in US Adults: Development and Validation Study.JMIR AI · 2025Article
- Innovations in early detection of chronic non-communicable diseases among adolescents through an easy-to-Use AutoML paradigm.Health care management science · 2025Observational
- A practical evaluation of AutoML tools for binary, multiclass, and multilabel classification.Scientific reports · 2025Article
- A comparative study of an on premise AutoML solution for medical image classification.Scientific reports · 2024Article
- Information and Communication Technology-Based Application for Cognitive Behavioral Therapy among Community-Dwelling Older Adults with Insomnia: Development and Validation Study.Healthcare (Basel, Switzerland) · 2024Article
- STM-ac4C: a hybrid model for identification of N4-acetylcytidine (ac4C) in human mRNA based on selective kernel convolution, temporal convolutional network, and multi-head self-attention.Frontiers in genetics · 2024Article
- Use Test of Automated Machine Learning in Cancer Diagnostics.Diagnostics (Basel, Switzerland) · 2023Article
- BioAutoMATED: An end-to-end automated machine learning tool for explanation and design of biological sequences.Cell systems · 2023Article
- AutoML accurately predicts endovascular mechanical thrombectomy in acute large vessel ischemic stroke.Frontiers in neurology · 2023Article
- Machine learning approaches in microbiome research: challenges and best practices.Frontiers in microbiology · 2023Review
- Polygenic risk modeling of tumor stage and survival in bladder cancer.BioData mining · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesAscertain and compare the performances of Automated Machine Learning (AutoML) tools on large, highly imbalanced healthcare datasets. MATERIALS AND
methodsWe generated a large dataset using historical de-identified administrative claims including demographic information and flags for disease codes in four different time windows prior to 2019. We then trained three AutoML tools on this dataset to predict six different disease outcomes in 2019 and evaluated model performances on several metrics.
resultsThe AutoML tools showed improvement from the baseline random forest model but did not differ significantly from each other. All models recorded low area under the precision-recall curve and failed to predict true positives while keeping the true negative rate high. Model performance was not directly related to prevalence. We provide a specific use-case to illustrate how to select a threshold that gives the best balance between true and false positive rates, as this is an important consideration in medical applications. DISCUSSION: Healthcare datasets present several challenges for AutoML tools, including large sample size, high imbalance, and limitations in the available features. Improvements in scalability, combinations of imbalance-learning resampling and ensemble approaches, and curated feature selection are possible next steps to achieve better performance.
conclusionAmong the three explored, no AutoML tool consistently outperforms the rest in terms of predictive performance. The performances of the models in this study suggest that there may be room for improvement in handling medical claims data. Finally, selection of the optimal prediction threshold should be guided by the specific practical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.